Irene Schilcher

Grambach, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Corrigendum to "Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice" [MOLMET 85 (2024) 1-16].

Corrigendum to "Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice" [MOLMET 85 (2024) 1-16].

Journal: Molecular metabolism
Published: June 26, 2024

Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice.

Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice.

Journal: Molecular metabolism
Published: February 19, 2024

Astaxanthin enhances autophagy, amyloid beta clearance and exerts anti-inflammatory effects in in vitro models of Alzheimer's disease-related blood brain barrier dysfunction and inflammation.

Astaxanthin enhances autophagy, amyloid beta clearance and exerts anti-inflammatory effects in in vitro models of Alzheimer's disease-related blood brain barrier dysfunction and inflammation.

Journal: Brain research
Published: May 31, 2023

Hydroxychloroquine lowers Alzheimer's disease and related dementias risk and rescues molecular phenotypes related to Alzheimer's disease.

Hydroxychloroquine lowers Alzheimer's disease and related dementias risk and rescues molecular phenotypes related to Alzheimer's disease.

Journal: Molecular psychiatry
Published: April 09, 2022

No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer's disease and related dementia: results from the Drug Repurposing for Effective Alzheimer's Medicines study.

No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer's disease and related dementia: results from the Drug Repurposing for Effective Alzheimer's Medicines study.

Journal: Brain communications
Published: January 14, 2022

A brain proteomic signature of incipient Alzheimer's disease in young APOE ε4 carriers identifies novel drug targets.

A brain proteomic signature of incipient Alzheimer's disease in young APOE ε4 carriers identifies novel drug targets.

Journal: Science advances
Published: November 10, 2021

Bispecific Tau Antibodies with Additional Binding to C1q or Alpha-Synuclein.

Bispecific Tau Antibodies with Additional Binding to C1q or Alpha-Synuclein.

Journal: Journal of Alzheimer's disease : JAD
Published: February 13, 2021

Endothelial Lipase Modulates Paraoxonase 1 Content and Arylesterase Activity of HDL.

Endothelial Lipase Modulates Paraoxonase 1 Content and Arylesterase Activity of HDL.

Journal: International journal of molecular sciences
Published: December 18, 2020

Neurofilament-Light Chain as Biomarker of Neurodegenerative and Rare Diseases With High Translational Value.

Neurofilament-Light Chain as Biomarker of Neurodegenerative and Rare Diseases With High Translational Value.

Journal: Frontiers in neuroscience
Published: February 10, 2020

Characterization of the visceral and neuronal phenotype of 4L/PS-NA mice modeling Gaucher disease.

Characterization of the visceral and neuronal phenotype of 4L/PS-NA mice modeling Gaucher disease.

Journal: PloS one
Published: September 04, 2019

Endothelial lipase increases eNOS activating capacity of high-density lipoprotein.

Endothelial lipase increases eNOS activating capacity of high-density lipoprotein.

Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids
Published: June 28, 2019

Endothelial lipase increases antioxidative capacity of high-density lipoprotein.

Endothelial lipase increases antioxidative capacity of high-density lipoprotein.

Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids
Published: December 05, 2018
Showing 1-12 of 14

Last Updated: 09/26/2026